- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06705309
Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer
The Effect of a Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer on Women's Prevention Methods
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cervical cancer is the fourth most common cancer among women worldwide and ranks ninth in Turkey, making it the second most common gynecological cancer. This highlights the significance of cervical cancer both globally and within Turkey. The prevention of this cancer is heavily reliant on identifying risk factors, implementing effective preventive measures, and ensuring early diagnosis. These factors play a crucial role in reducing the incidence of cervical cancer and improving the outcomes for affected individuals.
Cervical cancer is primarily associated with high-risk Human Papilloma Virus (HPV) infections, which are transmitted mainly through sexual contact. In fact, 99.7% of cervical cancer cases are linked to HPV infection. Understanding the risk factors for HPV and cervical cancer is essential for prevention. These risk-enhancing factors include early sexual activity, poor hygiene practices, low socioeconomic status, and immunosuppressive conditions, such as HIV infection or the use of immunosuppressive drugs.
To tackle this significant public health issue, the World Health Organization (WHO) launched the "Cervical Cancer Elimination Program," which sets ambitious goals to reduce the burden of cervical cancer by 2030. These goals include 90% of girls vaccinated against HPV by age 15, 70% of women aged 35-45 screened for cervical cancer, and 90% of women diagnosed with cervical cancer to have access to treatment. These targets are part of a broader effort to eliminate cervical cancer as a public health problem, aiming for a world where the incidence of cervical cancer is significantly reduced through vaccination, screening, and treatment accessibility.
Despite global efforts, there is a low participation rate in cervical cancer screening programs in Turkey, highlighting the urgent need to increase public awareness about the importance of early detection. Increasing awareness through educational campaigns can improve participation and, in turn, help reduce the incidence of cervical cancer.
Web-based education is increasingly recognized as an effective tool for promoting health behaviors and raising awareness on various health topics. Its key advantages include cost-effectiveness, accessibility, and convenience. Web-based programs are generally more affordable than in-person interventions and can reach a wide audience, including individuals who may not have easy access to healthcare facilities. Participants can engage with the content at their own pace, making it an attractive option for health education.
Studies have shown that web-based and video-based education can significantly enhance awareness about cervical cancer and encourage women to undergo preventive screenings, such as the Pap smear test, which is crucial for early detection.
The study developed a web-based education program and an educational booklet on cervical cancer, grounded in the Health Belief Model. This model focuses on individuals' perceptions of health risks and the benefits of taking preventive actions. The study aims to evaluate the impact of these educational tools on women's knowledge, attitudes, and behaviors regarding cervical cancer prevention. By assessing the effectiveness of these educational resources, the study aims to contribute to the dissemination of cervical cancer prevention methods and enrich the existing literature on the topic.
This research aims to provide valuable insights into how web-based education and educational booklets can be used to improve women's understanding of cervical cancer and enhance preventive behaviors. By contributing to public awareness and facilitating access to information, this study supports global and national efforts to reduce the burden of cervical cancer.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Avcılar, Turkey, 34320
- Istanbul University - Cerrahpasa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being between the ages of 30-65,
- Having never had a cervical cancer screening before,
- Having received training on cervical cancer,
- There is no obstacle to answering the questions physically, mathematically or spiritually,
- Having internet access,
- Being able to use a computer and/or tablet effectively,
- Academicians working in health programs,
- Healthy female academics who did not agree to participate in the research,
- Being able to use a computer
Exclusion Criteria:
- The emergence of any health problem that prevents the person from continuing the research,
- Not completing any of the required forms,
- Those who give up participating in the study at any stage of the study
- Do not visit 80% of the tabs in the web training program,
- Those who have never read the training booklet will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Web-Based Education Group
|
The Effect of a Web-Based Education Program and Educational Booklet Developed on Cervıcal Cancer on Women's Prevention Methods
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Effect of a Web-Based Education Program and Educational Booklet Developed on Cervical Cancer on Women's Prevention Methods
Time Frame: 1.5 year
|
To develop a web-based education program and an educational booklet on cervical cancer, and to assess the effectiveness of this program and booklet in improving women's knowledge, attitudes, and behaviors regarding cervical cancer prevention.
The evaluation will be based on pre- and post-intervention surveys measuring changes in participants' understanding of cervical cancer, their attitudes toward screening and prevention, and their behaviors related to cervical cancer prevention practices.
|
1.5 year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Ebru Sen, Istanbul University - Cerrahpasa
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Genital Diseases
- Urogenital Neoplasms
- Neoplasms by Site
- Neoplasms
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Uterine Diseases
- Genital Diseases, Female
- Genital Neoplasms, Female
- Uterine Cervical Diseases
- Uterine Neoplasms
- Uterine Cervical Neoplasms
Other Study ID Numbers
- Istanbul UniversityC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Cancer
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
M.D. Anderson Cancer CenterWithdrawnStage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage III Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO... and other conditions
-
Tata Memorial HospitalMahidol University; Juntendo University; Gunma University; Chiang Mai University...RecruitingStage IIA Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO 2018 | Stage IIIB Cervical Cancer FIGO 2018 | Stage IVA Cervical Cancer FIGO 2018 | Stage IB Cervical Cancer FIGO 2018India, Japan, Thailand
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingCervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Stage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical... and other conditionsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnCervical Cancer | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer
-
Qi ZhouNot yet recruitingCervical Cancer Recurrent | Cervical Cancer Metastatic
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingCervical Cancer Recurrent | Cervical Cancer Metastatic
-
National Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingCervical Large Cell Neuroendocrine Carcinoma | Cervical Neuroendocrine Carcinoma | Cervical Small Cell Carcinoma | Cervical Undifferentiated Carcinoma | Stage I Cervical Cancer AJCC v8 | Stage IA Cervical Cancer AJCC v8 | Stage IA1 Cervical Cancer AJCC v8 | Stage IA2 Cervical Cancer AJCC v8 | Stage... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IA Cervical Cancer | Stage IB Cervical Cancer | Stage IA1 Cervical Cancer | Stage IA2 Cervical Cancer | Stage IB1 Cervical Cancer | Stage IB2 Cervical Cancer | Stage IB3 Cervical CancerUnited States
Clinical Trials on Web-Based Education
-
Inonu UniversityCompletedEducation | NursingTurkey
-
KTO Karatay UniversityCompleted
-
KTO Karatay UniversityCompletedCOPD | Noninvasive VentilationTurkey
-
Siirt UniversityInonu UniversityCompletedDisability Physical | Genital InfectionTurkey
-
Karamanoğlu Mehmetbey UniversityKaradeniz Technical UniversityNot yet recruiting
-
Yuzuncu Yıl UniversityRecruiting
-
Yuzuncu Yıl UniversityCompletedBreastfeedingTurkey
-
Near East University, TurkeyCompletedDiabetes Mellitus, Type 2Turkey
-
Weill Medical College of Cornell UniversityWithdrawnAlzheimer Disease | Alzheimer Disease, Late Onset | Memory Loss | Patient Education as TopicUnited States
-
Ankara Yildirim Beyazıt UniversityCompleted